PLoS One. 2025 Dec 4;20(12):e0338397. doi: 10.1371/journal.pone.0338397. eCollection 2025. ABSTRACT BACKGROUND: Giant cell arteritis (GCA) is the leading vasculitis threatening […]
Clin J Am Soc Nephrol. 2025 Dec 4. doi: 10.2215/CJN.0000000905. Online ahead of print. ABSTRACT BACKGROUND: Nephronophthisis (NPH) is an
QD Clinic: Flare or Beware Lindsay Tom, PA-C and Phong Nguyen, MD, Reston, VA discuss today’s case called “Flare or
Survey of 500 Rheum Patients, 37% reported having APPs (NP or PA) as primary rheum providers. APP patients had greater
Low Dose Naltrexone in Fibromyalgia – Use it or Lose it? jjcush@gmail.com Thu, 12/04/2025 – 18:21
RheumNow Live 2026 Where the data meets the dialogue. Join leading rheumatologists, researchers, and innovators at Rheum https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
Retrospective cohort study of 546 DM or clinically amyopathic DM pts. 5 factors were signif assoc w/ cancers (1 point
DMARD Treatment Lags for Minority Groups with Rheumatoid Arthritis jjcush@gmail.com Thu, 12/04/2025 – 16:30
Consensus Definitions on Difficult to Treat PsA A substantial number of patients with PsA, have difficult, persistent https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
QD Clinic: CAR-T Cell Therapy for Lupus tammytilley@gm… Thu, 12/04/2025 – 15:42 Lupus Novel Rx Outcomes Philip Mease, MD and
We invited three experts with extensive experience in rheumatology and nursing research to provide professional guidance. The experts involved …
Rheumatol Ther. 2025 Dec 4. doi: 10.1007/s40744-025-00811-4. Online ahead of print. ABSTRACT INTRODUCTION: This study evaluated the real-world effectiveness of
Rheumatol Ther. 2025 Dec 4. doi: 10.1007/s40744-025-00805-2. Online ahead of print. ABSTRACT INTRODUCTION: The efficacy and safety of filgotinib (FIL)
Clin Rheumatol. 2025 Dec 4. doi: 10.1007/s10067-025-07864-4. Online ahead of print. NO ABSTRACT PMID:41343026 | DOI:10.1007/s10067-025-07864-4
Clin Rheumatol. 2025 Dec 4. doi: 10.1007/s10067-025-07695-3. Online ahead of print. ABSTRACT BACKGROUND: Axial spondyloarthritis (axSpA) is chronic autoimmune disease
Clin Rheumatol. 2025 Dec 4. doi: 10.1007/s10067-025-07847-5. Online ahead of print. ABSTRACT INTRODUCTION: Belimumab is a monoclonal antibody with proven
Z Rheumatol. 2025 Dec 4. doi: 10.1007/s00393-025-01760-7. Online ahead of print. ABSTRACT OBJECTIVE: Belimumab and anifrolumab are two biologic therapies
Osteoporos Int. 2025 Dec 4. doi: 10.1007/s00198-025-07769-7. Online ahead of print. NO ABSTRACT PMID:41342933 | DOI:10.1007/s00198-025-07769-7
Minerva Med. 2025 Dec 4. doi: 10.23736/S0026-4806.25.09781-2. Online ahead of print. ABSTRACT BACKGROUND: Fibromyalgia is characterized by widespread musculoskeletal pain,
Mod Rheumatol. 2025 Dec 4:roaf116. doi: 10.1093/mr/roaf116. Online ahead of print. ABSTRACT Obesity and metabolic syndrome play a significant role
Mod Rheumatol Case Rep. 2025 Dec 4:rxaf073. doi: 10.1093/mrcr/rxaf073. Online ahead of print. ABSTRACT Neutrophilic dermatoses (NDs) are a heterogeneous
… rheumatologist and geroscientist at Duke. … But, you know, but we often will talk about this topic within our
A 2022 Four Corners investigation uncovered disproportionate rates of rheumatic heart disease (RHD) in the outback Queensland town of Doomadgee.
Hematologic Malignancies Increased in Systemic Sclerosis Swedish national study found that among a cohort of systemic https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 12/04/2025
SAN DIEGO — Forty-three percent of medical residents report using generative AI-based tools daily, but many expressed concerns about overreliance
Conditions: Rheumatoid Arthritis (RA) Sponsors: Inonu University Not yet recruiting
Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals that promise to
